21/06/2024 Healthcare
Rabeprazole Injection IP, marketed as Satmorab-IV, is a potent intravenous medication used primarily for treating severe gastroesophageal reflux disease (GERD) and gastric ulcers. It belongs to the proton pump inhibitor class, effectively suppressing gastric acid secretion to alleviate symptoms such as heartburn and acid reflux. Satmorab-IV offers rapid onset of action, making it valuable in acute settings where oral therapy is not feasible. It ensures quick relief and management of acid-related gastrointestinal disorders.Available in PCD Franchise for injectable range and third party manufacturing.
Rabeprazole Injection IP, marketed as Satmorab-IV, is a potent intravenous medication used primarily for treating severe gastroesophageal reflux disea...
Vancomycin Hydrochloride for Injection IP, branded as Satdox-500 Injection, is a potent antibiotic used to treat severe infections caused by Gram-posi...
Tranexamic Acid injection IP, branded as Tamslar Injection, is a hemostatic agent used to control excessive bleeding in various medical conditions. Ad...
Triamcinolone Acetonide Injection IP, known as Tioxlin-40 Injection, is a corticosteroid used for its anti-inflammatory and immunosuppressive properti...
More Details